Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1971 Nov;33(6):889–894. doi: 10.1136/hrt.33.6.889

Clinical, electrocardiographic, and haemodynamic effects of long-term use of propranolol in Prinzmetal's variant angina pectoris.

M Guazzi, F Magrini, C Fiorentini, A Polese
PMCID: PMC458444  PMID: 5120235

Full text

PDF
889

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amsterdam E. A., Gorlin R., Wolfson S. Evaluation of long-term use of propranolol in angina pectoris. JAMA. 1969 Oct 6;210(1):103–106. [PubMed] [Google Scholar]
  2. BEECHER H. K. Appraisal of drugs intended to alter subjective responses, symptoms. J Am Med Assoc. 1955 Jun 4;158(5):399–401. [PubMed] [Google Scholar]
  3. BRAUNWALD E., SARNOFF S. J., STAINSBY W. N. Determinants of duration and mean rate of ventricular ejection. Circ Res. 1958 May;6(3):319–325. doi: 10.1161/01.res.6.3.319. [DOI] [PubMed] [Google Scholar]
  4. Epstein S., Robinson B. F., Kahler R. L., Braunwald E. Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest. 1965 Nov;44(11):1745–1753. doi: 10.1172/JCI105282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GLEASON W. L., BRAUNWALD E. Studies on the first derivative of the ventricular pressure pulse in man. J Clin Invest. 1962 Jan;41:80–91. doi: 10.1172/JCI104469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GORLIN R. PATHOPHYSIOLOGY OF CARDIAC PAIN. Circulation. 1965 Jul;32:138–148. doi: 10.1161/01.cir.32.1.138. [DOI] [PubMed] [Google Scholar]
  7. Gianelly R. E., Goldman R. H., Treister B., Harrison D. C. Propranolol in patients with angina pectoris. Ann Intern Med. 1967 Dec;67(6):1216–1225. doi: 10.7326/0003-4819-67-6-1216. [DOI] [PubMed] [Google Scholar]
  8. Ginn W. M., Jr, Orgain E. S. Propranolol hydrochloride in the treatment of angina pectoris. JAMA. 1966 Dec 12;198(11):1214–1216. [PubMed] [Google Scholar]
  9. Grant R. H., Keelan P., Kernohan R. J., Leonard J. C., Nancekievill L., Sinclair K. Multicenter trial of propranolol in angina pectoris. Am J Cardiol. 1966 Sep;18(3):361–365. doi: 10.1016/0002-9149(66)90054-3. [DOI] [PubMed] [Google Scholar]
  10. Hamer J., Sowton E. Cardiac output after beta-adrenergic blockade in ischaemic heart disease. Br Heart J. 1965 Nov;27(6):892–895. doi: 10.1136/hrt.27.6.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hamer J., Sowton E. Effects of propranolol on exercise tolerance in angina pectoris. Am J Cardiol. 1966 Sep;18(3):354–360. doi: 10.1016/0002-9149(66)90053-1. [DOI] [PubMed] [Google Scholar]
  12. Hebb A. R., Godwin T. F., Gunn R. W. A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris. Can Med Assoc J. 1968 Feb 3;98(5):246–251. [PMC free article] [PubMed] [Google Scholar]
  13. Jezek V. Rate of right ventricular isometric pressure increase in the patients with chronic cor pulmonale studied by the ventricular pressure derivative curves. Cardiologia. 1966;48(5):461–470. [PubMed] [Google Scholar]
  14. KEELAN P. DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS. Br Med J. 1965 Apr 3;1(5439):897–898. doi: 10.1136/bmj.1.5439.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nakano J., Kusakari T. Effect of beta adrenergic blockade on the cardiovascular dynamics. Am J Physiol. 1966 Apr;210(4):833–837. doi: 10.1152/ajplegacy.1966.210.4.833. [DOI] [PubMed] [Google Scholar]
  16. PRINZMETAL M., KENNAMER R., MERLISS R., WADA T., BOR N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med. 1959 Sep;27:375–388. doi: 10.1016/0002-9343(59)90003-8. [DOI] [PubMed] [Google Scholar]
  17. Parker J. O., West R. O., Di Giorgi S. Hemodynamic effects of propranolol in coronary heart disease. Am J Cardiol. 1968 Jan;21(1):11–19. doi: 10.1016/0002-9149(68)90007-6. [DOI] [PubMed] [Google Scholar]
  18. Robin E., Cowan C., Puri P., Ganguly S., DeBoyrie E., Martinez M., Stock T., Bing R. J. A comparative study of nitroglycerin and propranolol. Circulation. 1967 Aug;36(2):175–186. doi: 10.1161/01.cir.36.2.175. [DOI] [PubMed] [Google Scholar]
  19. Short D. The earliest electrocardiographic evidence of myocardial infarction. Br Heart J. 1970 Jan;32(1):6–15. doi: 10.1136/hrt.32.1.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sonnenblick E. H., Braunwald E., Williams J. F., Jr, Glick G. Effects of exercise on myocardial force-velocity relations in intact unanesthetized man: relative roles of changes in heart rate, sympathetic activity, and ventricular dimensions. J Clin Invest. 1965 Dec;44(12):2051–2062. doi: 10.1172/JCI105312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Weissler A. M., Harris W. S., Schoenfeld C. D. Systolic time intervals in heart failure in man. Circulation. 1968 Feb;37(2):149–159. doi: 10.1161/01.cir.37.2.149. [DOI] [PubMed] [Google Scholar]
  22. Wolfson S., Gorlin R. Cardiovascular pharmacology of propranolol in man. Circulation. 1969 Oct;40(4):501–511. doi: 10.1161/01.cir.40.4.501. [DOI] [PubMed] [Google Scholar]
  23. Wolfson S., Heinle R. A., Herman M. V., Kemp H. G., Sullivan J. M., Gorlin R. Propranolol and angina pectoris. Am J Cardiol. 1966 Sep;18(3):345–353. doi: 10.1016/0002-9149(66)90052-x. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES